Table 3 Comparison between the 4 groups regarding the enlisted variables:
Group | P value | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Group A | Group B | Group C | Group D | |||||||
N | % | N | % | N | % | N | % | |||
HTN | No | 91 | 91.0 | 88 | 88.0 | 86 | 86.0 | 87 | 87.0 | 0.723 |
Yes | 9 | 9.0 | 12 | 12.0 | 14 | 14.0 | 13 | 13.0 | ||
BMI | BMI < 20 | 20 | 20.0 | 38 | 38.0 | 26 | 26.0 | 43 | 43.0 | < 0.001 |
BMI 20–25 | 28 | 28.0 | 39 | 39.0 | 46 | 46.0 | 34 | 34.0 | ||
BMI 25–29 | 36 | 36.0 | 16 | 16.0 | 18 | 18.0 | 16 | 16.0 | ||
BMI > 30 | 16 | 16.0 | 7 | 7.0 | 10 | 10.0 | 7 | 7.0 | ||
Ultrasound | Normal | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | |
Fatty liver | 100 | 100.0 | 100 | 100.0 | 100 | 100.0 | 100 | 100.0 | ||
HBA1C | Normal | 0 | 0.0 | 100 | 100.0 | 0 | 0.0 | 100 | 100.0 | < 0.001 |
On target | 56 | 56.0 | 0 | 0.0 | 56 | 56.0 | 0 | 0.0 | ||
Elevated | 44 | 44.0 | 0 | 0.0 | 44 | 44.0 | 0 | 0.0 | ||
T.G | Normal | 52 | 52.0 | 0 | 0.0 | 28 | 28.0 | 20 | 20.0 | < 0.001 |
High | 48 | 48.0 | 100 | 100.0 | 72 | 72.0 | 80 | 80.0 | ||
Cholesterol | Normal | 52 | 52.0 | 0 | 0.0 | 28 | 28.0 | 20 | 20.0 | < 0.001 |
High | 48 | 48.0 | 100 | 100.0 | 72 | 72.0 | 80 | 80.0 | ||
FIB-4 score | Low | 44 | 44.0 | 44 | 44.0 | 0 | 0.0 | 34 | 34.0 | < 0.001 |
Intermediate | 32 | 32.0 | 30 | 30.0 | 82 | 82.0 | 47 | 47.0 | ||
High risk | 24 | 24.0 | 26 | 26.0 | 18 | 18.0 | 19 | 19.0 | ||
Fibro scan steatosis % | S0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0.005 |
S1 | 0 | 0.0 | 4 | 16.0 | 3 | 17.6 | 4 | 16.7 | ||
S2 | 16 | 66.7 | 12 | 48.0 | 13 | 76.5 | 20 | 83.3 | ||
S3 | 8 | 33.3 | 9 | 36.0 | 1 | 5.9 | 0 | 0.0 | ||
Fibro scan fibrosis | F1 | 12 | 33.3 | 6 | 24.0 | 7 | 41.2 | 5 | 20.8 | 0.351 |
F2 | 12 | 33.3 | 14 | 56.0 | 7 | 41.2 | 14 | 58.3 | ||
F3 | 12 | 33.3 | 4 | 16.0 | 3 | 17.6 | 5 | 20.8 | ||
F4 | 0 | 0.0 | 1 | 4.0 | 0 | 0.0 | 0 | 0.0 | ||
